Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals

被引:2
|
作者
Deboever, Nathaniel [1 ]
Correa, Arlene M. [1 ]
Feldman, Hope [1 ]
Mathur, Urvashi [2 ]
Hofstetter, Wayne L. [1 ]
Mehran, Reza J. [1 ]
Rice, David C. [1 ]
Roth, Jack A. [1 ]
Sepesi, Boris [1 ]
Swisher, Stephen G. [1 ]
Walsh, Garrett L. [1 ]
Vaporciyan, Ara A. [1 ]
Antonoff, Mara B. [1 ]
Rajaram, Ravi [1 ,3 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX USA
[2] Univ Texas Rio Grande Valley, Sch Med, Edinburg, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, 1515 Holcombe Blvd,Box 1489, Houston, TX 77030 USA
关键词
health disparity; minority-serving hospital; minority; non-small cell lung cancer; health care system barrier; RACIAL-DIFFERENCES; SURGERY; RACE; DECISIONS; CARE;
D O I
10.1016/j.jtcvs.2023.04.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Disparities in cancer care are omnipresent and originate from a multilevel set of barriers. Our objectives were to describe the likelihood of undergoing surgery for early-stage non-small cell lung cancer at minority-serving hospitals (MSHs), and evaluate the association of race/ethnicity with resection based on MSH status. Methods: A retrospective study using the National Cancer Database (2008-2016) was conducted including patients with clinical stage I non-small cell lung cancer. MSHs were defined as hospitals in the top decile of providing care to Hispanic or African American patients. The primary outcome evaluated was receipt of definitive surgery at MSHs vs non-MSHs. Outcomes related to race/ethnicity stratified by hospital type were also investigated.Results: A total of 142,580 patients were identified from 1192 hospitals (120 MSHs and 1072 non-MSHs). Most patients (85% [n =121,240]) were non-Hispanic White, followed by African American (9% [n = 12,772]), and Hispanic (3%, [n= 3749]). MSHs cared for 7.4% (n = 10,491) of the patients included. In adjusted analyses, patients treated at MSHs were resected less often than those at non-MSHs (odds ratio, 0.87; 95% CI, 0.76-1.00; P = .0495). African American patients were less likely to receive surgery in the overall analysis (P <.01), and at MSHs specifically (P <.01), compared with non-Hispanic White patients. Hispanic patients had similar rates of resection in the overall analysis (P = .11); however, at MSHs, they underwent surgery more often compared with non-Hispanic White patients (P = .02). Resected patients at MSHs had similar overall survival (median, 91.7 months; 95% CI, 86.6-96.8 months) compared with those resected at non-MSHs (median, 85.7 months; 95% CI, 84.5-86.8 months).Conclusions: Patients with early-stage non-small cell lung cancer underwent resection less often at MSHs compared with non-MSHs. Disparities related to underutilization of surgery for African American patients continue to persist, regardless of hospital type.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Non-Small Cell Lung Cancer: A SEER Cohort Study
    Mehta, Rohtesh S.
    Lenzner, Diana
    Argiris, Athanassios
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (03) : 722 - 727
  • [42] Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy (SBRT) Outcomes in an Equal Access Military Setting
    Chaurasia, Avinash R.
    White, John
    Beckmann, Robert C.
    Chamberlin, Michael
    Horn, Adam
    Torgeson, Anna M.
    Skinner, William
    Erickson, Delnora
    Reed, Aaron
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (02)
  • [43] Disparities in Access to Multidisciplinary Cancer Consultations and Treatment for Patients With Early-Stage Non-Small Cell Lung Cancer: A SEER-Medicare Analysis
    Liu, You-Chi
    Schmidt, Rachel O.
    Kapadia, Nirav S.
    Phillips, Joseph D.
    Moen, Erika L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (01): : 102 - 110
  • [44] Early-Stage Non-Small Cell Lung Cancer Stereotactic Body Radiation Therapy Outcomes in a Single Institution
    Doupnik, Nathan P.
    Hirmiz, Khalid
    Hussein, Abdulkadir A.
    Agapito, John
    Pan, Ming
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [45] Early outcomes of robotic versus thoracoscopic segmentectomy for early-stage lung cancer: A multi-institutional propensity score-matched analysis
    Zhang, Yajie
    Chen, Chun
    Hu, Jian
    Han, Yu
    Huang, Maosheng
    Xiang, Jie
    Li, Hecheng
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 160 (05) : 1363 - 1372
  • [46] Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer
    Cheng, Chao
    Nguyen, Thinh T.
    Tang, Mabel
    Wang, Xinan
    Jiang, Chongming
    Liu, Yanhong
    Gorlov, Ivan
    Gorlova, Olga
    Iafrate, John
    Lanuti, Michael
    Christiani, David C.
    Amos, Christopher I.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (09) : 1184 - 1198
  • [47] Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD: a cohort study
    Kang, Noeul
    Shin, Sun Hye
    Noh, Jae Myoung
    Kang, Danbee
    Kim, Hojoong
    Kwon, O. Jung
    Pyo, Hongryull
    Ahn, Yong Chan
    Kim, Hong Kwan
    Choi, Yong Soo
    Kim, Jhingook
    Zo, Jae Ill
    Shim, Young Mog
    Cho, Juhee
    Park, Hye Yun
    JOURNAL OF THORACIC DISEASE, 2020, 12 (09) : 4651 - +
  • [48] Polymorphisms in Folate Metabolism Related Genes Affect the Survival Outcomes of Early-Stage Non-Small Cell Lung Cancer
    Choi, S. H.
    Do, S. K.
    Choi, J. E.
    Yoo, S. S.
    Lee, S. Y.
    Park, J. Y.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S726 - S726
  • [49] Real-World Outcomes of Patients with Resectable Early-Stage Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemoimmunotherapy
    Hazim, A.
    Xiao, A.
    Singh, A.
    Chung, K.
    dos Santos, P. A. Reck
    D'Cunha, J.
    Shanshal, M.
    Dimou, A.
    Parikh, K.
    Lou, Y.
    Manochakian, R.
    Leventakos, K.
    Molina, J.
    Mansfield, A.
    Ernani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S546 - S547
  • [50] Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry
    Davis, Joanne N.
    Medbery, Clinton, III
    Sharma, Sanjeev
    Perry, David
    Pablo, John
    D'Ambrosio, David J.
    McKellar, Heidi
    Kimsey, Frank C.
    Chomiak, Paul N.
    Mahadevan, Anand
    JOURNAL OF RADIATION ONCOLOGY, 2015, 4 (01) : 55 - 63